<img src="/images/nav_ra.png" />

A / A / A

The Dilemma of Obamacare

The commentary below is for the benefit of our readers from opinion makers and writers not associated with Euro Pacific. We do not guarantee the accuracy and completeness of third-party authored content. Opinions expressed are those of the writer, and may or may not reflect those held by Euro Pacific, or its CEO, Peter Schiff.
Mario Rizzo
March 24, 2010

The very factors responsible for the passage of Obamacare may make it impossible to fund it adequately. There are certain myths about medical care that make it difficult to contain costs. The central myth, in not very exaggerated form, is that any care less than the best for anyone is the result of a contrived scarcity. If insurance companies were not so greedy for profit people could have the best care they deserve.

Spurred on by irresponsible politicians, many people object to attempts by insurance companies to save money by denying coverage for pre-existing conditions or treatments whose efficacy has not been proven, refusing to exceed certain pre-agreed-upon lifetime or yearly caps, exclusion of dental care, (previously) poor reimbursement for psychiatric services, and so forth.

So the supporters of Obamacare turned to government to make things better. Government will eliminate the contrived scarcity insurance market. (Of course, this is contrived by greed, even though this sector is already highly-regulated and filled with mandates.)

However, for Obamacare to work fiscally certain healthcare savings must materialize. Why? Well, because we live in a world of scarcity. Medical technologies and new drugs can be quite expensive. They can have small, but often noticeable benefits, in diagnosing, curing or alleviating illness. Some may give people just an extra few months of life or make what remains of higher quality.

But many people have an enduring faith that government knows how to eliminate greed in the provision of healthcare and to distribute it “fairly” when true scarcity raises its head.

In the first place, we do not have any generally-agreed upon notion of fairness when it comes to the allocation of (medical) resources. Second, because of this there is plenty of room for politically powerful interest groups to push resources in their own direction under the banner of fairness.

Greg Mankiw helpfully published some of the cost-savings caveats that the Congressional Budget Office issued as a supplement to their cost estimates for the latest bill:

The reconciliation proposal and H.R. 3590 would maintain and put into effect a number of policies that might be difficult to sustain over a long period of time. Under current law, payment rates for physicians' services in Medicare would be reduced by about 21 percent in 2010 and then decline further in subsequent years; the proposal makes no changes to those provisions. At the same time, the legislation includes a number of provisions that would constrain payment rates for other providers of Medicare services. In particular, increases in payment rates for many providers would be held below the rate of inflation (in expectation of ongoing productivity improvements in the delivery of health care). The projected longer-term savings for the legislation also reflect an assumption that the Independent Payment Advisory Board established by H.R. 3590 would be fairly effective in reducing costs beyond the reductions that would be achieved by other aspects of the legislation.

Under the legislation, CBO expects that Medicare spending would increase significantly more slowly during the next two decades than it has increased during the past two decades (per beneficiary, after adjusting for inflation). It is unclear whether such a reduction in the growth rate of spending could be achieved, and if so, whether it would be accomplished through greater efficiencies in the delivery of health care or through reductions in access to care or the quality of care. The long-term budgetary impact could be quite different if key provisions of the legislation were ultimately changed or not fully implemented.

It seems to me that seniors are a very powerful interest group when it comes to getting health-care resources. And I have no doubt that they will be able to put a sympathy-inducing face on their plight. They will say there is “no need” to cut their services to provide services to others. They will find some greed somewhere to blame for this – perhaps the greed of the rich who don't pay enough in taxes.

This is how it will go. Decisions will be politicized, and not made in accordance with the ideas of an Ethics Tsar.

Some will no doubt say that government-sponsored healthcare takes money out of medical decisions. Instead of rationing by ability to pay we shall have allocation by other, better criteria.

Yet the criteria of special interests (with money) are not obviously better than willingness to pay. At least the latter has the advantage of spurring innovation.

What we need is a recognition that not everyone can get the best care all of the time and that resources must be used efficiently. The question is will this be done in a market-friendly way (medical savings accounts, competition of insurance companies across state lines, etc.) or by central direction?

This, as always, is the question of our age.

Mario J. Rizzo, PhD is a professor of economics and co-director of the Austrian Economics Program at New York University. He currently lectures for the Institute for Humane Studies and is an adjunct scholar of the Cato Institute. He blogs at ThinkMarkets.

Check the background of our investment professionals on FINRA’s BrokerCheck.

Investing in foreign securities involves risks, such as currency fluctuation, political risk, economic changes, and market risks. Precious metals and commodities in general are volatile, speculative, and high-risk investments. As with all investments, an investor should carefully consider his investment objectives and risk tolerance as well as any fees and/or expenses associated with such an investment before investing. International investing may not be suitable for all investors.

Dividend yields change as stock prices change, and companies may change or cancel dividend payments in the future. The fluctuation of foreign currency exchange rates will impact your investment returns. Past performance does not guarantee future returns, investments may increase or decrease in value and you may lose money.

Our investment strategies are based partially on Peter Schiff's personal economic forecasts which may not occur. His views are outside of the mainstream of current economic thought. Investors should carefully consider these facts before implementing our strategy.